|
|
Article: ACCUMETRICS' VERIFYNOW P2Y12 TEST PROVIDES PHYSICIANS WITH INFO.
- Article from:
- AsiaPulse News
- Article date:
- July 15, 2009
CopyrightCOPYRIGHT 2009 Asia Pulse Pty Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MEDIA RELEASE PR35383
(Full text of statement. Contact details below.)
Accumetrics' VerifyNow(R) P2Y12 Test Provides Physicians With Information to Assess a Patient's Response to Newly-Approved Prasugrel (Effient(R))
SAN DIEGO, July 14 /PRNewswire-AsiaNet -- With the recent FDA approval of the new P2Y12 inhibitor, prasugrel (Effient), Accumetrics, Inc. announces that its VerifyNow P2Y12 Test is not only able to assess response to Plavix(R), but also its newly approved competitor, Effient. In obtaining a result from the VerifyNow System, physicians are provided objective information to determine the response of an individual patient to their ...